118 related articles for article (PubMed ID: 15869593)
21. Coagulation factor XII protease domain crystal structure.
Pathak M; Wilmann P; Awford J; Li C; Hamad BK; Fischer PM; Dreveny I; Dekker LV; Emsley J
J Thromb Haemost; 2015 Apr; 13(4):580-91. PubMed ID: 25604127
[TBL] [Abstract][Full Text] [Related]
22. Single-chain factor XII exhibits activity when complexed to polyphosphate.
Engel R; Brain CM; Paget J; Lionikiene AS; Mutch NJ
J Thromb Haemost; 2014 Sep; 12(9):1513-22. PubMed ID: 25039405
[TBL] [Abstract][Full Text] [Related]
23. Human Hageman factor (factor XII) and high molecular weight kininogen compete for the same binding site on human umbilical vein endothelial cells.
Reddigari SR; Shibayama Y; Brunnée T; Kaplan AP
J Biol Chem; 1993 Jun; 268(16):11982-7. PubMed ID: 8505323
[TBL] [Abstract][Full Text] [Related]
24. A nanobody-based method for tracking factor XII activation in plasma.
de Maat S; van Dooremalen S; de Groot PG; Maas C
Thromb Haemost; 2013 Sep; 110(3):458-68. PubMed ID: 23349032
[TBL] [Abstract][Full Text] [Related]
25. Factor XII Osaka: abnormal factor XII with partially defective prekallikrein cleavage activity.
Iijima K; Arakawa Y; Sugahara Y; Matsushita M; Moriguchi Y; Shimohiro H; Nakagawa M
Thromb Haemost; 2011 Mar; 105(3):473-8. PubMed ID: 21264442
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
27. The Fibronectin Type II Domain of Factor XII Ensures Zymogen Quiescence.
Clark CC; Hofman ZLM; Sanrattana W; den Braven L; de Maat S; Maas C
Thromb Haemost; 2020 Mar; 120(3):400-411. PubMed ID: 31940673
[TBL] [Abstract][Full Text] [Related]
28. Autoantibodies to Factor XII and Kininogen-Dependent Antiphosphatidylethanolamine Antibodies in Patients with Recurrent Pregnancy Loss Augment Platelet Aggregation.
Sato Y; Sugi T; Sakai R
Am J Reprod Immunol; 2015 Sep; 74(3):279-89. PubMed ID: 26011374
[TBL] [Abstract][Full Text] [Related]
29. Proteolytic properties of single-chain factor XII: a mechanism for triggering contact activation.
Ivanov I; Matafonov A; Sun MF; Cheng Q; Dickeson SK; Verhamme IM; Emsley J; Gailani D
Blood; 2017 Mar; 129(11):1527-1537. PubMed ID: 28069606
[TBL] [Abstract][Full Text] [Related]
30. The outcome of ELISA for antiphosphatidylethanolamine antibodies is dependent on the composition of phosphatidylethanolamine.
Hou S; Harper PE; Bardin N; Zhao M
J Immunol Methods; 2017 Jan; 440():27-34. PubMed ID: 27784626
[TBL] [Abstract][Full Text] [Related]
31. Immobilized transition metal ions stimulate contact activation and drive factor XII-mediated coagulation.
Mutch NJ; Waters EK; Morrissey JH
J Thromb Haemost; 2012 Oct; 10(10):2108-15. PubMed ID: 22905925
[TBL] [Abstract][Full Text] [Related]
32. Identification of a peptide mimicking the binding pattern of an antiphospholipid antibody.
Fischer C; Buschmann K; Blank M; Stachl A; Miesbach W; Shoenfeld Y; Lackner KJ; von Landenberg P
Immunobiology; 2006; 211(9):695-9. PubMed ID: 17015144
[TBL] [Abstract][Full Text] [Related]
33. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
Sugi T; McIntyre JA
Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
[TBL] [Abstract][Full Text] [Related]
34. Factor XII truncation accelerates activation in solution.
de Maat S; Clark CC; Boertien M; Parr N; Sanrattana W; Hofman ZLM; Maas C
J Thromb Haemost; 2019 Jan; 17(1):183-194. PubMed ID: 30394658
[TBL] [Abstract][Full Text] [Related]
35. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371).
Page JD; Colman RW
J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772
[TBL] [Abstract][Full Text] [Related]
36. Immunoblotting studies of coagulation factor XII, plasma prekallikrein, and high molecular weight kininogen.
Lämmle B; Berrettini M; Griffin JH
Semin Thromb Hemost; 1987 Jan; 13(1):106-14. PubMed ID: 3494310
[TBL] [Abstract][Full Text] [Related]
37. Differential binding of factor XII and activated factor XII to soluble and immobilized fibronectin--localization of the Hep-1/Fib-1 binding site for activated factor XII.
Schousboe I; Nystrøm BT; Hansen GH
FEBS J; 2008 Oct; 275(20):5161-72. PubMed ID: 18793325
[TBL] [Abstract][Full Text] [Related]
38. Enzymes produced by autoactivation of blood factor XII in buffer: A contribution from the Hematology at Biomaterial Interfaces Research Group.
Golas A; Pitakjakpipop H; Rahn MS; Siedlecki CA; Vogler EA
Biomaterials; 2015 Jan; 37():1-12. PubMed ID: 25443791
[TBL] [Abstract][Full Text] [Related]
39. Antibodies to factor XII and recurrent fetal loss in patients with the anti-phospholipid syndrome.
Jones DW; MacKie IJ; Gallimore MJ; Winter M
Br J Haematol; 2001 May; 113(2):550-2. PubMed ID: 11380430
[TBL] [Abstract][Full Text] [Related]
40. Factor XII in coagulation, inflammation and beyond.
Didiasova M; Wujak L; Schaefer L; Wygrecka M
Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
